Tenax Therapeutics Ownership 2024 | Who Owns Tenax Therapeutics Now?


OverviewRevenueFinancialsChart

Institutional Ownership

0.00%

Insider Ownership

0.36%

Institutional Holders

1.00

Tenax Therapeutics Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CI PRIVATE WEALTH, LLC13.62%0.00%191,460191,460100.00%89,029,000Mar 31, 2023
STATE STREET CORP6.77%-95,12295,122100.00%44,232,000Mar 31, 2023
VIRTU FINANCIAL LLC6.00%0.00%84,36184,361100.00%39,000Mar 31, 2023
VERITION FUND MANAGEMENT LLC3.10%0.00%43,57943,579100.00%20,264,000Mar 31, 2023
TWO SIGMA SECURITIES, LLC3.06%0.00%42,99542,995100.00%19,993,000Mar 31, 2023
BLACKROCK INC.1.70%-23,92223,922100.00%11,124,000Mar 31, 2023
AVANTAX PLANNING PARTNERS, INC.0.71%0.00%10,00210,002100.00%4,651,000Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)0.33%0.00%4,6974,697100.00%2,000Mar 31, 2023
MORGAN STANLEY0.05%-680680100.00%316,000Mar 31, 2023
WELLS FARGO & COMPANY/MN0.00%-6464100.00%30,000Mar 31, 2023
TUCKER ASSET MANAGEMENT LLC0.00%-22100.00%1,000Mar 31, 2023
ALLWORTH FINANCIAL LP0.00%-11100.00%1,000Mar 31, 2023
WELLS FARGO & COMPANY/MN----13-100.00%-Mar 31, 2023
UBS GROUP AG----8,049-100.00%-Mar 31, 2023
BLACKROCK INC.----23,954-100.00%-Mar 31, 2023
NORTHERN TRUST CORP----1,734-100.00%-Mar 31, 2023
MORGAN STANLEY----680-100.00%-Mar 31, 2023
STATE STREET CORP----6,921-100.00%-Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC----3,169-100.00%-Mar 31, 2023
ACADIAN ASSET MANAGEMENT LLC----60,501-100.00%-Mar 31, 2023

Tenax Therapeutics's largest institutional shareholder is CI PRIVATE WEALTH, LLC, holding 13.62% of the company's total share outstanding, currently valued at $89.03M. The top 10 institutional shareholders own together 35.34% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
VIRTU FINANCIAL LLC6.00%0.00%84,36184,361100.00%39,000Mar 31, 2023
TWO SIGMA SECURITIES, LLC3.06%0.00%42,99542,995100.00%19,993,000Mar 31, 2023
VERITION FUND MANAGEMENT LLC3.10%0.00%43,57943,579100.00%20,264,000Mar 31, 2023
CI PRIVATE WEALTH, LLC13.62%0.00%191,460191,460100.00%89,029,000Mar 31, 2023
AVANTAX PLANNING PARTNERS, INC.0.71%0.00%10,00210,002100.00%4,651,000Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)0.33%0.00%4,6974,697100.00%2,000Mar 31, 2023
STATE STREET CORP6.77%-95,12295,122100.00%44,232,000Mar 31, 2023
BLACKROCK INC.1.70%-23,92223,922100.00%11,124,000Mar 31, 2023
TUCKER ASSET MANAGEMENT LLC0.00%-22100.00%1,000Mar 31, 2023
MORGAN STANLEY0.05%-680680100.00%316,000Mar 31, 2023
ALLWORTH FINANCIAL LP0.00%-11100.00%1,000Mar 31, 2023
WELLS FARGO & COMPANY/MN0.00%-6464100.00%30,000Mar 31, 2023
MORGAN STANLEY----680-100.00%-Mar 31, 2023
BLACKROCK INC.----23,954-100.00%-Mar 31, 2023
NORTHERN TRUST CORP----1,734-100.00%-Mar 31, 2023
STATE STREET CORP----6,921-100.00%-Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC----3,169-100.00%-Mar 31, 2023
ACADIAN ASSET MANAGEMENT LLC----60,501-100.00%-Mar 31, 2023
HRT FINANCIAL LP----1,293-100.00%-Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)----477-100.00%-Mar 31, 2023

The largest Tenax Therapeutics shareholder by % of total assets is VIRTU FINANCIAL LLC. The company owns 84.36K shares of Tenax Therapeutics (TENX), representing 0.00% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CI PRIVATE WEALTH, LLC13.62%0.00%191,460191,460100.00%89,029,000Mar 31, 2023
STATE STREET CORP6.77%-95,12295,122100.00%44,232,000Mar 31, 2023
VIRTU FINANCIAL LLC6.00%0.00%84,36184,361100.00%39,000Mar 31, 2023
VERITION FUND MANAGEMENT LLC3.10%0.00%43,57943,579100.00%20,264,000Mar 31, 2023
TWO SIGMA SECURITIES, LLC3.06%0.00%42,99542,995100.00%19,993,000Mar 31, 2023
BLACKROCK INC.1.70%-23,92223,922100.00%11,124,000Mar 31, 2023
AVANTAX PLANNING PARTNERS, INC.0.71%0.00%10,00210,002100.00%4,651,000Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)0.33%0.00%4,6974,697100.00%2,000Mar 31, 2023
MORGAN STANLEY0.05%-680680100.00%316,000Mar 31, 2023
WELLS FARGO & COMPANY/MN0.00%-6464100.00%30,000Mar 31, 2023
TUCKER ASSET MANAGEMENT LLC0.00%-22100.00%1,000Mar 31, 2023
ALLWORTH FINANCIAL LP0.00%-11100.00%1,000Mar 31, 2023
TUCKER ASSET MANAGEMENT LLC----2-100.00%-Mar 31, 2023
PNC FINANCIAL SERVICES GROUP, INC.----10-100.00%-Mar 31, 2023
WELLS FARGO & COMPANY/MN----13-100.00%-Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)----477-100.00%-Mar 31, 2023
MORGAN STANLEY----680-100.00%-Mar 31, 2023
HRT FINANCIAL LP----1,293-100.00%-Mar 31, 2023
NORTHERN TRUST CORP----1,734-100.00%-Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC----2,561-100.00%-Mar 31, 2023

As of Mar 31 2023, Tenax Therapeutics's largest institutional buyer is CI PRIVATE WEALTH, LLC. The company purchased 191.46K stocks of TENX, valued at $89.03M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ACADIAN ASSET MANAGEMENT LLC----60,501-100.00%-Mar 31, 2023
BLACKROCK INC.----23,954-100.00%-Mar 31, 2023
VANGUARD GROUP INC----8,691-100.00%-Mar 31, 2023
UBS GROUP AG----8,049-100.00%-Mar 31, 2023
STATE STREET CORP----6,921-100.00%-Mar 31, 2023
TWO SIGMA SECURITIES, LLC----3,387-100.00%-Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC----3,169-100.00%-Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC----2,561-100.00%-Mar 31, 2023
NORTHERN TRUST CORP----1,734-100.00%-Mar 31, 2023
HRT FINANCIAL LP----1,293-100.00%-Mar 31, 2023
MORGAN STANLEY----680-100.00%-Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)----477-100.00%-Mar 31, 2023
WELLS FARGO & COMPANY/MN----13-100.00%-Mar 31, 2023
PNC FINANCIAL SERVICES GROUP, INC.----10-100.00%-Mar 31, 2023
TUCKER ASSET MANAGEMENT LLC----2-100.00%-Mar 31, 2023
ALLWORTH FINANCIAL LP0.00%-11100.00%1,000Mar 31, 2023
TUCKER ASSET MANAGEMENT LLC0.00%-22100.00%1,000Mar 31, 2023
WELLS FARGO & COMPANY/MN0.00%-6464100.00%30,000Mar 31, 2023
MORGAN STANLEY0.05%-680680100.00%316,000Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)0.33%0.00%4,6974,697100.00%2,000Mar 31, 2023

As of Mar 31 2023, Tenax Therapeutics's biggest institutional seller is ACADIAN ASSET MANAGEMENT LLC. The company sold -60.50K shares of TENX, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CI PRIVATE WEALTH, LLC13.62%0.00%191,460191,460100.00%89,029,000Mar 31, 2023
STATE STREET CORP6.77%-95,12295,122100.00%44,232,000Mar 31, 2023
VIRTU FINANCIAL LLC6.00%0.00%84,36184,361100.00%39,000Mar 31, 2023
VERITION FUND MANAGEMENT LLC3.10%0.00%43,57943,579100.00%20,264,000Mar 31, 2023
TWO SIGMA SECURITIES, LLC3.06%0.00%42,99542,995100.00%19,993,000Mar 31, 2023
BLACKROCK INC.1.70%-23,92223,922100.00%11,124,000Mar 31, 2023
AVANTAX PLANNING PARTNERS, INC.0.71%0.00%10,00210,002100.00%4,651,000Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)0.33%0.00%4,6974,697100.00%2,000Mar 31, 2023
MORGAN STANLEY0.05%-680680100.00%316,000Mar 31, 2023
WELLS FARGO & COMPANY/MN0.00%-6464100.00%30,000Mar 31, 2023
TUCKER ASSET MANAGEMENT LLC0.00%-22100.00%1,000Mar 31, 2023
ALLWORTH FINANCIAL LP0.00%-11100.00%1,000Mar 31, 2023

Tenax Therapeutics's largest new institutional shareholder by number of shares is CI PRIVATE WEALTH, LLC, purchased 191.46K shares, valued at $89.03M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ACADIAN ASSET MANAGEMENT LLC----60,501-100.00%-Mar 31, 2023
BLACKROCK INC.----23,954-100.00%-Mar 31, 2023
VANGUARD GROUP INC----8,691-100.00%-Mar 31, 2023
UBS GROUP AG----8,049-100.00%-Mar 31, 2023
STATE STREET CORP----6,921-100.00%-Mar 31, 2023
TWO SIGMA SECURITIES, LLC----3,387-100.00%-Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC----3,169-100.00%-Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC----2,561-100.00%-Mar 31, 2023
NORTHERN TRUST CORP----1,734-100.00%-Mar 31, 2023
HRT FINANCIAL LP----1,293-100.00%-Mar 31, 2023
MORGAN STANLEY----680-100.00%-Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)----477-100.00%-Mar 31, 2023
WELLS FARGO & COMPANY/MN----13-100.00%-Mar 31, 2023
PNC FINANCIAL SERVICES GROUP, INC.----10-100.00%-Mar 31, 2023
TUCKER ASSET MANAGEMENT LLC----2-100.00%-Mar 31, 2023

Tenax Therapeutics's largest sold out institutional shareholder by shares sold is ACADIAN ASSET MANAGEMENT LLC, sold -60.50K shares, valued at -, as of undefined.

Tenax Therapeutics Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
VANGUARD INDEX FUNDS0.00%372,092363,4014181.35%Dec 31, 2023
FIDELITY CONCORD STREET TRUST0.00%148,118--Feb 29, 2024
VANGUARD INDEX FUNDS0.00%173,801--Dec 31, 2023
FIDELITY CONCORD STREET TRUST0.00%51,179--Feb 29, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%12,186--Jan 31, 2024
EQ ADVISORS TRUST0.00%2,134--Dec 31, 2023

Tenax Therapeutics's largest mutual fund holder by % of total assets is "VANGUARD INDEX FUNDS", owning 372.09K shares, compromising 0.00% of its total assets.

Tenax Therapeutics Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 231-95.24%
31 Dec, 2215-21.05%
30 Sep, 221926.67%
30 Jun, 2215-
31 Mar, 2215-6.25%
31 Dec, 211614.29%
30 Sep, 2114-12.50%
30 Jun, 21166.67%
31 Mar, 2115-6.25%
31 Dec, 20166.67%
30 Sep, 2015-11.76%
30 Jun, 201788.89%
31 Mar, 209-10.00%
31 Dec, 1910-16.67%
30 Sep, 191233.33%
30 Jun, 199-
31 Mar, 199-10.00%
31 Dec, 181066.67%
30 Sep, 186-25.00%
30 Jun, 18814.29%
31 Mar, 187-

As of 31 Mar 23, 1 institutions are holding Tenax Therapeutics's shares, representing a decrease of -95.24% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 23--100.00%
31 Dec, 222,428,685-66.57%
30 Sep, 227,265,1774.85%
30 Jun, 226,928,902-14.27%
31 Mar, 228,082,2940.25%
31 Dec, 218,062,3904.55%
30 Sep, 217,711,585120.01%
30 Jun, 213,505,165-7.67%
31 Mar, 213,796,31612.40%
31 Dec, 203,377,498-16.63%
30 Sep, 204,051,30976.18%
30 Jun, 202,299,51549.91%
31 Mar, 201,533,97123.74%
31 Dec, 191,239,6421.85%
30 Sep, 191,217,1789.40%
30 Jun, 191,112,58210.33%
31 Mar, 191,008,37296.12%
31 Dec, 18514,159191.74%
30 Sep, 18176,2371.56%
30 Jun, 18173,5349.53%
31 Mar, 18158,432-

Tenax Therapeutics (TENX) has 0.00 shares outstanding as of 31 Mar 23, down -100.00% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 23--
31 Dec, 2226.11%0.43%
30 Sep, 2278.11%1.41%
30 Jun, 2274.50%0.99%
31 Mar, 2286.90%1.16%
31 Dec, 2186.69%1.26%
30 Sep, 2182.91%3.28%
30 Jun, 2150.26%1.70%
31 Mar, 2154.43%2.32%
31 Dec, 2048.43%1.44%
30 Sep, 2058.09%5.34%
30 Jun, 2032.97%6.82%
31 Mar, 2021.99%6.96%
31 Dec, 1917.77%5.84%
30 Sep, 1917.45%3.37%
30 Jun, 1922.77%5.35%
31 Mar, 1920.63%18.64%
31 Dec, 1810.52%80.90%
30 Sep, 183.61%28.60%
30 Jun, 183.55%33.79%
31 Mar, 183.24%-

As of 31 Mar 23, Tenax Therapeutics is held by 0.00% institutional shareholders, representing a 0.00% growth compared to 31 Dec 22.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 23--100.00%
31 Dec, 226-45.45%
30 Sep, 2211120.00%
30 Jun, 22566.67%
31 Mar, 223-57.14%
31 Dec, 21716.67%
30 Sep, 216-25.00%
30 Jun, 21860.00%
31 Mar, 215-
31 Dec, 205-16.67%
30 Sep, 206-53.85%
30 Jun, 2013333.33%
31 Mar, 203-25.00%
31 Dec, 194-33.33%
30 Sep, 196100.00%
30 Jun, 193-25.00%
31 Mar, 194-42.86%
31 Dec, 187600.00%
30 Sep, 181-80.00%
30 Jun, 185-28.57%
31 Mar, 187-

- institutional shareholders have increased their position in TENX stock as of 31 Mar 23 compared to 6 in the previous quarter (a -100.00% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 23--100.00%
31 Dec, 224300.00%
30 Sep, 221-66.67%
30 Jun, 223-25.00%
31 Mar, 224100.00%
31 Dec, 212-
30 Sep, 212-50.00%
30 Jun, 21433.33%
31 Mar, 213-25.00%
31 Dec, 20433.33%
30 Sep, 203200.00%
30 Jun, 201-66.67%
31 Mar, 203-
31 Dec, 19--
30 Sep, 19--100.00%
30 Jun, 19350.00%
31 Mar, 192100.00%
31 Dec, 181-
30 Sep, 181-
30 Jun, 181-
31 Mar, 18--

- institutional shareholders have reduced their position in TENX stock as of 31 Mar 23 compared to 4 in the previous quarter (a -100.00% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 231-95.24%--100.00%----100.00%--100.00%
31 Dec, 2215-21.05%2,428,685-66.57%26.11%0.43%6-45.45%4300.00%
30 Sep, 221926.67%7,265,1774.85%78.11%1.41%11120.00%1-66.67%
30 Jun, 2215-6,928,902-14.27%74.50%0.99%566.67%3-25.00%
31 Mar, 2215-6.25%8,082,2940.25%86.90%1.16%3-57.14%4100.00%
31 Dec, 211614.29%8,062,3904.55%86.69%1.26%716.67%2-
30 Sep, 2114-12.50%7,711,585120.01%82.91%3.28%6-25.00%2-50.00%
30 Jun, 21166.67%3,505,165-7.67%50.26%1.70%860.00%433.33%
31 Mar, 2115-6.25%3,796,31612.40%54.43%2.32%5-3-25.00%
31 Dec, 20166.67%3,377,498-16.63%48.43%1.44%5-16.67%433.33%
30 Sep, 2015-11.76%4,051,30976.18%58.09%5.34%6-53.85%3200.00%
30 Jun, 201788.89%2,299,51549.91%32.97%6.82%13333.33%1-66.67%
31 Mar, 209-10.00%1,533,97123.74%21.99%6.96%3-25.00%3-
31 Dec, 1910-16.67%1,239,6421.85%17.77%5.84%4-33.33%--
30 Sep, 191233.33%1,217,1789.40%17.45%3.37%6100.00%--100.00%
30 Jun, 199-1,112,58210.33%22.77%5.35%3-25.00%350.00%
31 Mar, 199-10.00%1,008,37296.12%20.63%18.64%4-42.86%2100.00%
31 Dec, 181066.67%514,159191.74%10.52%80.90%7600.00%1-
30 Sep, 186-25.00%176,2371.56%3.61%28.60%1-80.00%1-
30 Jun, 18814.29%173,5349.53%3.55%33.79%5-28.57%1-
31 Mar, 187-158,432-3.24%-7---

Tenax Therapeutics Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jan 12, 2024HOFFMAN LAWRENCE Rofficer Interim CFOSell----
Sep 23, 2022Rich Stuartdirector, 10 percent owner, officer Chief Medical OfficerG-GiftSell1,909,585--424,347
Aug 12, 2022Doogan Declandirector G-GiftSell567,871---
May 19, 2022Boyd Stevendirector D-ReturnSell2,072,538---
Apr 12, 2022Almenoff June Sheriedirector-Sell----
Jan 31, 2022Hunter Robyndirector-Sell----

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jan 12, 2024HOFFMAN LAWRENCE Rofficer Interim CFOSell----
Sep 23, 2022Rich Stuartdirector, 10 percent owner, officer Chief Medical OfficerG-GiftBuy1,909,585--1,909,585
Sep 23, 2022Rich Stuartdirector, 10 percent owner, officer Chief Medical OfficerG-GiftSell1,909,585--424,347
Aug 12, 2022Doogan Declandirector G-GiftSell567,871---
Jun 10, 2022Rich Stuartdirector Chief Medical OfficerA-AwardBuy100,000--100,000
Jun 10, 2022Rich Stuartdirector, 10 percent owner, officer Chief Medical OfficerA-AwardBuy100,000$0.62$62.00K100,000
Jun 10, 2022PROEHL GERALD Tdirector A-AwardBuy5,000--5,000
Jun 10, 2022PROEHL GERALD Tdirector-A-AwardBuy5,000$0.62$3.10K5,000
Jun 10, 2022Hunter Robyndirector A-AwardBuy6,250--6,250
Jun 10, 2022Hunter Robyndirector-A-AwardBuy6,250$0.62$3.88K6,250
Jun 10, 2022Giordano Christopher Thomasdirector CEOA-AwardBuy200,000--200,000
Jun 10, 2022Doogan Declandirector A-AwardBuy5,000--5,000
Jun 10, 2022Davidson Michael H.director A-AwardBuy5,000--5,000
Jun 10, 2022Davidson Michael H.director-A-AwardBuy5,000$0.62$3.10K5,000
Jun 10, 2022Almenoff June Sheriedirector A-AwardBuy5,000--5,000
Jun 10, 2022Almenoff June Sheriedirector-A-AwardBuy5,000$0.62$3.10K5,000
May 19, 2022Boyd Stevendirector A-AwardBuy10,596,027--10,596,027
May 19, 2022Boyd Stevendirector D-ReturnSell2,072,538---
Apr 12, 2022Almenoff June Sheriedirector-Sell----
Jan 31, 2022Hunter Robyndirector-Sell----

The last insider sell of Tenax Therapeutics's stock was made by HOFFMAN LAWRENCE R on Jan 12 2024, selling - shares at - per share (valued at -).

Tenax Therapeutics Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q1 2024-1-
Q3 2022-1-
Q2 202281800.00%
Q1 2022-1-
Q4 20212366.67%
Q3 202131300.00%
Q2 202184200.00%
Q1 202155100.00%
Q3 2020264650.00%
Q2 20205--
Q1 202021200.00%
Q2 20191--
Q4 2018-1-
Q3 20181--
Q2 20185--
Q1 20181--
Q4 201731300.00%
Q3 20171--
Q2 20172--
Q1 201711100.00%

0 total buy trades, and 1 total sell trades (buy/sell ratio of 0.00%) were made by Tenax Therapeutics's insiders, as of Q1 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q1 2024---
Q3 2022---
Q2 2022---
Q1 2022---
Q4 2021---
Q3 2021---
Q2 2021---
Q1 2021---
Q3 202026--
Q2 20201--
Q1 2020---
Q2 2019---
Q4 2018---
Q3 2018---
Q2 2018---
Q1 2018---
Q4 201721200.00%
Q3 2017---
Q2 2017---
Q1 2017---

As of Q1 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Tenax Therapeutics's stocks.

Tenax Therapeutics Peer Ownership


TickerCompany
ZVSAZyVersa Therapeutics, Inc.
VRAXVirax Biolabs Group Limited
QNRXQuoin Pharmaceuticals, Ltd.
ENSCEnsysce Biosciences, Inc.
PBLAPanbela Therapeutics, Inc.
UNCYUnicycive Therapeutics, Inc.
BWVOnconetix, Inc.
PXMDPaxMedica, Inc. Common Stock
REVBRevelation Biosciences, Inc.
NRBONeuroBo Pharmaceuticals, Inc.
WINTWindtree Therapeutics, Inc.
CYTOAltamira Therapeutics Ltd.
ADTXAditxt, Inc.
HILSTharimmune, Inc.
ALLRAllarity Therapeutics, Inc.
DRMADermata Therapeutics, Inc.
BXRXBaudax Bio, Inc.
SONNSonnet BioTherapeutics Holdings, Inc.

TENX Ownership FAQ


Tenax Therapeutics is owned by institutional shareholders (0%), insiders (0.36%), and public (0%). The largest institutional shareholder of Tenax Therapeutics is CI PRIVATE WEALTH, LLC (13.62% of total shares) and the top mutual fund owner is VANGUARD INDEX FUNDS (0.00% of total shares).

Tenax Therapeutics's major institutional shareholders are CI PRIVATE WEALTH, LLC, STATE STREET CORP, VIRTU FINANCIAL LLC, VERITION FUND MANAGEMENT LLC, and TWO SIGMA SECURITIES, LLC. The top five shareholders own together 32.54% of the company's share outstanding.

As of Mar 2023, there are 1 institutional shareholders of Tenax Therapeutics.

CI PRIVATE WEALTH, LLC owns 191.46K shares of Tenax Therapeutics, representing 13.62% of the company's total shares outstanding, valued at $89.03M (as of Mar 2023).

As of Mar 2023, STATE STREET CORP holds 95.12K shares of Tenax Therapeutics (TENX), compromising 6.77% of the company, valued at $44.23M.

VIRTU FINANCIAL LLC is the third largest holder of Tenax Therapeutics. The company owns 84.36K of the company's shares outstanding (worth $39K).